EyePoint Pharmaceuticals, Inc. — Director's Dealing 2009

Mar 27, 2009

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2009-03-21

Reporting Person: Ross Leonard S (Corporate Controller)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to purchase CHESS Depositary Interests (?CDIs?)	$8.9596	2011-09-30	CDIs (7500)		Direct
Employee Stock Option (right to buy)	$2.85	2018-09-11	Common Stock (40000)		Direct

Footnotes

F1: 2,500 options vested on each of October 18, 2007 and October 18, 2008, and the final 2,500 options vest on October 18, 2009.

F2: The option becomes exercisable in four equal annual installments beginning on September 11, 2009.

F3: Each CDI represents an interest in one underlying share of common stock of pSivida Corp.

F4: Per CDI. The exercise price was converted from A$13.00 using the noon-day rate of exchange of the Federal Reserve Bank of New York on March 20, 2009, which was US$0.6892 = A$1.00. The actual exercise price will be the Australian dollar amount regardless of the exchange rate on the date of grant or of exercise.